Is CBD legaal ?

“Is CBD Legaal ?” Dit is een van de meest gestelde vragen die mensen stellen wanneer ze voor het eerst horen over CBD Oil (Cannabidiol) en andere producten die CBD bevatten. Als u CBD Oil wilt proberen maar niet zeker bent van de legaliteit in uw land en wilt weten wat de huidige regels en voorschriften zijn, dan kan dit artikel u misschien helpen.

Aangezien de wetten echter snel veranderen, mag geen enkele informatie in dit artikel als juridisch advies worden beschouwd. Raadpleeg altijd je plaatselijke overheidsfunctionaris, politiebureau of douanekantoor voor de meest recente informatie..

Nederland

Onze producten zijn gewoon legaal voor de wet  01#Artikel 15 opium wet

Lijst II

Preparaten die één of meer van de bovengenoemde substanties bevatten, met uitzondering van hennepolie.

 http://wetten.overheid.nl/BWBR0001941/2016-08-01#Artikel15

We zijn niet in staat om informatie te geven over welke gezondheidsclaim dan ook met betrekking tot CBD.

Raadpleeg altijd uw arts!
ons advies is om dit ALTIJD eerst met uw ARTS te bespreken. Wij doen géén medische uitspraken de informatie op deze pagina is niet bedoeld om te diagnosticeren, behandelen, genezen

Landen waar CBD legaal is

Argentina Austria Belgium Belize Brazil Bulgaria Canada Chile China Colombia Costa Rica Croatia Cyprus Czech Republic Denmark Estonia Finland France Georgia Germany Greece Guam Guatemala Hong Kong Hungary Iceland India Ireland Italy Latvia Lithuania Luxembourg Netherlands Netherlands Antilles Northern Ireland Norway Paraguay Peru Poland Portugal Puerto Rico Romania Russia Slovenia South Africa Sweden Switzerland U.S. Virgin Islands Uruguay
In de volgende landen wordt CBD als legaal beschouwd en zou u geen problemen mogen ondervinden bij het importeren van CBD-olie of andere CBD-producten, zolang deze maar een te verwaarlozen THC-gehalte hebben.

United Nations
Cannabidiol is not scheduled by the Convention on Psychotropic Substances.

https://en.wikipedia.org/wiki/Cannabidiol

United States

In the United States, cannabidiol is a Schedule I drug under the Controlled Substances Act. This means that production, distribution and possession of CBD is illegal under federal law. In 2016, the Drug Enforcement Administration added “marihuana extracts” to the list of Schedule I drugs, which it defined as “an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant.”Previously, CBD had simply been considered “marijuana,” which is also a Schedule I drug.

A CNN program that featured Charlotte’s Web cannabis in 2013 brought increased attention to the use of CBD in the treatment of seizure disorders. Since then, 17 states have passed laws to allow for the use of CBD products (not exceeding a specified concentration of THC) for the treatment of certain medical conditions.This is in addition to the 29 states that have passed comprehensive medical cannabis laws, which allow for the use of cannabis products with no restrictions on THC content. Of these 29 states, 8 have legalized the use and sale of cannabis products without requirement for a doctor’s recommendation.

Although most states restrict the use of CBD products to certain medical conditions, manufacturers of CBD claim their products are derived from industrial hemp, and therefore legal for anyone to use. A number of these manufacturers ship CBD products to all 50 states, which the federal government has so far not intervened in. CBD is also openly sold in head shops and health food stores in some states where such sales have not been explicitly legalized.

Australia

Prescription medicine (Schedule 4) for therapeutic use containing 2 per cent (2.0%) or less of other cannabinoids commonly found in cannabis (such as ∆9-THC). A schedule 4 drug under the SUSMP is Prescription Only Medicine, or Prescription Animal Remedy – Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription.

New Zealand

Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.

Associate Health Minister Peter Dunne said restrictions would be removed, which means a doctor will now be able to prescribe cannabidiol to patients.

Canada

Cannabidiol is a Schedule II drug in Canada. As such, it is only available with a prescription. It is available as a spray, called Sativex produced by GW Pharmaceuticals in the UK, for use in multiple sclerosis. The Canadian Government has passed its recreational legalization bill, which will come into effect on July 1, 2018, which will erase the necessity to obtain prescriptions for commercial CBD, as well as provision of cannabis federally to its citizens for recreational use.

Europe

Cannabidiol is listed in the EU Cosmetics Ingredient Database (CosIng).However, the listing of an ingredient, assigned with an INCI name, in CosIng does not mean it is to be used in cosmetic products nor approved for such use.

Cannabidiol is listed in the EU Novel Food Catalogue.This listing only applies to isolated or synthetic CBD, not to crude hemp extracts or tinctures naturally containing CBD.

The European Industrial Hemp Association has issued a position paper suggesting regulatory framework in EU.

Several industrial hemp varieties can be legally cultivated in western Europe. A variety such as “Fedora 17” has a cannabinoid profile consistently around 1% cannabidiol (CBD) with THC less than 0.1%.

Although the World Health Organization listed Cannabidiolum in a list of International Nonproprietary Names for Pharmaceutical Substances (INN) on 30 June 2016. French and Spanish versions wrongly mention agonist action of CBD on cannabinoid receptors while the English version says CBD is a cannabinoid receptor antagonist.[citation needed]

Sweden

CBD is not classified in Sweden.

Sativex (CBD and THC) is a prescription product available for relief of severe spasticity due to multiple sclerosis.

United Kingdom

Cannabidiol, in an oral-mucosal spray formulation combined with delta-9-tetrahydrocannabinol, is a prescription product available for relief of severe spasticity due to multiple sclerosis (where other anti-spasmodics have not been effective).

As of 31 December 2016, products containing cannabidiol that are marketed for medical purposes are classed as medicines by the UK regulatory body, the Medicines and Healthcare products Regulatory Agency (MHRA) and cannot be marketed without regulatory approval for the medical claims.

Switzerland

While THC remains illegal, CBD is not subject to the Swiss Narcotic Acts because this substance does not produce a comparable psychoactive effect. Cannabis products containing less than 1% THC can be sold and purchased legally.

Argentina Austria Belgium Belize Brazil Bulgaria Canada Chile China Colombia Costa Rica Croatia Cyprus Czech Republic Denmark Estonia Finland France Georgia Germany Greece Guam Guatemala Hong Kong Hungary Iceland India Ireland Italy Latvia Lithuania Luxembourg Netherlands Netherlands Antilles Northern Ireland Norway Paraguay Peru Poland Portugal Puerto Rico Romania Russia  Slovenia South Africa Sweden Switzerland U.S. Virgin Islands  Uruguay   

http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:42000A0922(02):en:HTML

Countries Where CBD is Legal